Tinea Corporis, Cruris & Pedis Disease Summary

Last updated: 21 April 2026

Overview

Dermatophytoses are superficial fungal infections that have different presentations and are named based on location, as stated in the Introduction section.

Dermatophytoses are highly prevalent worldwide, and dermatophytes represent the most common pathogens responsible for superficial fungal infections. A detailed discussion about the prevalence of dermatophytoses is in the Epidemiology section.

Discussions on the different dermatophytes that cause tinea corporis, cruris, and pedis are in the Etiology section.

The Pathophysiology section states that individual susceptibility to fungal infections varies with familial and genetic factors and are likely tied to defects in both innate and adaptive immunity. The developmental process and transmission of dermatophytoses in infected patients are in this section.

The Risk Factors section includes the conditions that are associated with the development of dermatophyte infections.



Tinea Corporis, Cruris and Pedis_Disease SummaryTinea Corporis, Cruris and Pedis_Disease Summary

History and Physical Examination

The Clinical Presentation section describes the clinical features of patients with tinea corporis, cruris, and pedis.

The History section enumerates the information needed in the evaluation of dermatophytoses, while the Physical Examination section emphasizes the importance of the location and appearance of skin lesions for proper identification of the causative agent. 

Diagnosis

Discussions on microscopy, culture, and polymerase chain reaction (PCR) are in the Laboratory Tests and Ancillaries section. 

Other diseases that may have similar presentations to tinea infections and should be excluded are listed in the Differential Diagnosis section.

Management

The goals of therapy and management of dermatophyte infections are in the Principles of Therapy section.

The Pharmacological Therapy section discusses therapies such as topical and oral antifungals, topical corticosteroids, and the optimal vehicles of topical treatment.

The Nonpharmacological section includes things to educate the patient about the management of dermatophytoses.